2017: A Big Year for AbSci – Growth and Continued Expansion

2017: A Big Year for AbSci – Growth and Continued Expansion

AbSci, a global leader in breakthrough biomanufacturing technologies, today announced that it is further expanding its offices and laboratory facilities. “We’ve seen a significant increase in partnership deal flow, which is a testament to the innovation and quality of work performed by our scientists,” said CEO and Founder, Sean McClain …

AbSci Raises Series B Financing

AbSci Raises Series B Financing

AbSci, a global leader in breakthrough biomanufacturing technologies, announced that it closed its Series B financing round for an undisclosed amount. The round includes previous investors along with several new investors …

US Patent Granted for SoluPro™ Technology

US Patent Granted for SoluPro™ Technology

Vancouver, WA – April 11, 2017 United States Patent No. 9,617,335 was issued today to AbSci, an industry leader in biomanufacturing innovation, for its SoluPro™ protein expression system, which produces complex therapeutic proteins at unparalleled yield and throughput...